UK Investor Magazine

CelLBxHealth (LON: CLBX) is collaborating with AdventHealth in the US for two studies monitoring circulating tumour cells. The studies, titled ACTION and SUNRISE, will use Parsortix technology to monitor blood samples of patients undertaking treatment. The share price jumped 59.1% to 1.75p. Richard and Charlotte Edwards have increased their shareholding in agriculture company...

Time to ACT (LON: TTA) says that Ruth Herbert has been appointed chief executive of EET Hydrogen and power, which is a potential client, and final investment decision for the HPP1 blue hydrogen project is due in the second half of 2026. Time to ACT has completed the acquisition of MTE Heat Treatment for £500,000. […]

The post

Medical devices developer Creo Medical (LON: CREO) has raised £5.5m at 15p/share and the Bank of Wales is subscribing for £2m of convertible loan notes. Creo Medical plans to sell the remaining 49% interest in Creo Medical SL to 51% shareholder CME at book value. The sale of the 51% stake raised £24.7m after costs […]

The post

The FTSE 100 was higher on Friday as hopes of a peace deal between Iran and the US boosted sentiment going into the bank holiday weekend. But we’ve been here before and traders didn’t get ahead of themselves with the FTSE 100 adding just 0.5% as of the time of writing. “The market, having been […]

The post

Currency trading now moves at a pace that leaves little room for instinct alone. In many cases, success depends less on bold predictions and more on disciplined execution backed by data. Through structured analysis, traders can stay more consistent in a market where conditions change quickly and timing often matters. The global foreign exchange market […]

The post